Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/12/2018
Sanpower Sell Dendreon to Affiliate Nanjing Cenbest for $820M
8/10/2018
Recent Executive Moves
8/9/2018
Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
8/9/2018
SMIA Official: BMI Negotiation for 18 Anticancers To Be Concluded by S...
8/9/2018
China Approves Amgen's Anti-cholesterol Drug Repatha
8/9/2018
Harbour BioMed and Glenmark Pharma Sign Agreement for Greater China to...
8/8/2018
CDE Solicits Comments on List of Urgently-needed New Drugs Marketed Ov...
8/8/2018
IQVIA: Overview of the Chinese Pharmaceutical Market in 2017
8/8/2018
Novartis Voluntarily Withdraws Zemeta for Injection in China, Followin...
8/7/2018
MorphoSys and I-Mab Announce China IND Submission of mAb for MM
8/7/2018
State Council Issues New Guideline to Enhance Medical Sector Regulatio...
8/7/2018
Can-Fite and with CMS Medical Sign License Agreement for Piclidenoson ...
8/6/2018
Harbour BioMed and Glenmark Pharma Sign Anticancer License Agreement f...
8/3/2018
Recent Executive Moves
8/3/2018
China Isn't Yet Ready to Conduct Clinical Trials for The Pharma Indust...
8/3/2018
Nobel Laureate to Launch Biomedicine Laboratory in Shenzhen
8/3/2018
Acticor Licenses Stroke Medicine to CMS in China and Select Asian Mark...
8/2/2018
Clover Biopharma Initiates Phase I Study of Etanercept Biosimilar in C...
8/1/2018
SMIA to Hold Meeting Seeking Feedbacks on the Upcoming National Level ...
7/31/2018
Korea's SillaJen and Medytox Prepare for China Business Takeoffs
7/27/2018
CNDA Announces Adjustment of Drug Clinical Trial Evaluation and Approv...
7/27/2018
Recent Executive Moves
7/27/2018
Neovii Licenses Transplant Drug Grafalon In China And Japan
7/27/2018
Bio-Thera Initiates Phase I Trial for Biosimilar of Actemra (Tocilizum...
7/27/2018
I-Mab and ABL Bio Announce Partnership on Novel Bispecific Antibodies
7/26/2018
CBT Pharma Initiates Phase 1b Trial for Anti-PD-1 Antibody Drug
7/26/2018
First National Drug Supply Consortium Formed under Government Guidance
7/26/2018
SMIA: Urban and Rural Resident BMI Programs To Be Uniformed in 2019
7/26/2018
MSD Announces Chinese Approval of Its Blockbuster Anticancer Drug Keyt...
7/26/2018
China Presses Pharma Cos to Lower Anticancer Drug Prices As Prevalence...
Page:
158
/
357
Total number of articles:
10705
:
[First]
[<<]
[156]
[157]
[158]
[159]
[160]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit